1. Federal Register, Vol. 68, No. 123, 26 June 2003. Notices
2. Federal Register, Vol. 70, No. 56, 24 March 2005. Notices
3. FDA reorganization, intended to streamline review process for biologics;Christensen;J. Natl. Cancer Inst.,2003
4. McClellan, M. (2003) Expanding FDA's Mission, U.S. Medicine January
5. Pollack, A. (2002) Biotech and FDA: blame game, New York Times, 16 December